# LongeVC

LongeVC is a Private Equity based in San Francisco, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** San Francisco, United States
- **Region:** Europe
- **Address:** San Francisco, CA, United States
- **Founded:** 2020
- **Assets under management:** Undisclosed
- **Website:** longevc.com
- **LinkedIn:** https://www.linkedin.com/company/longevc
- **Wikidata:** Q125743906

## Regulatory record

- **Reports private funds:** No

## About

LongeVC is a venture capital firm investing in an ageless future. Through supporting exceptional early stage founders, its mission is to bring breakthrough biotech to market. The firm curates an ecosystem of biotech and longevity-focused companies and connects founders with a global network of thought leaders.

## Sectors

- Digital Health
- AI/ML
- Biotech

## Offices

- Santa Monica, CA
- New York, NY
- San Diego, CA
- Switzerland

## People

- Sergey Jakimov — Founding Partner
- Garry Zmudze — Founding Partner
- Ilya Suharenko — Managing Partner

## Questions

### What is LongeVC's investment thesis?

LongeVC invests in early-stage companies applying biotechnology, artificial intelligence, and decentralized science to extend healthy human lifespan. The firm specifically targets projects where blockchain or token-based mechanisms can improve research funding, IP ownership, or clinical data coordination — areas it considers underserved by both traditional biotech venture and generalist crypto funds. The thesis rests on the view that longevity research is undercapitalized relative to its potential impact and that decentralized capital formation can close that gap.

### Does LongeVC invest only in tokens, or does it take equity positions?

The firm invests through both equity and token positions, often within the same company. LongeVC uses a Token-for-Equity model in which it acquires equity in a biotech startup while simultaneously helping the company design and launch token-based research funding mechanisms. The fund also makes direct liquid token investments and participates in early-stage equity rounds, giving it exposure to both traditional venture returns and digital-asset upside.

### Who makes investment decisions at LongeVC?

Founding Partners Sergey Jakimov and Garry Zmudze, alongside Managing Partner Ilya Suharenko, lead the firm's investment decisions. The partnership brings combined expertise in computational biology, distributed-systems engineering, and venture capital. The firm has not publicly detailed an investment committee structure beyond the named partners.

### How does LongeVC source its deals?

LongeVC sources deals through deep engagement with decentralized science communities, longevity research networks, and blockchain developer ecosystems — channels that generalist healthcare funds rarely access. The firm's presence in both US biotech hubs and European research centers, combined with its partners' technical credibility in Web3-native circles, gives it visibility into projects before they reach broader venture attention. Specific sourcing mechanisms — whether proprietary events, advisor networks, or inbound from portfolio company referrals — have not been publicly detailed.

### What is the relationship between Longevity Science Foundation and LongeVC?

LongeVC's founders are associated with the Longevity Science Foundation, a Swiss-based nonprofit that funds aging research, but the two entities are structurally separate. The foundation operates as a grant-making and research-funding organization, while LongeVC is a for-profit venture firm. Overlap in leadership and thematic focus creates a research pipeline that can inform investment decisions, but the foundation does not invest in portfolio companies and LongeVC does not direct the foundation's grant allocation.

## Related profiles

- [Long Capital](https://altss.com/profile/long-capital)
- [Longevity Tech Fund](https://altss.com/profile/longevity-tech-fund)

---

Last updated: 2026-08-11T15:07:19.634Z

Canonical page: https://altss.com/profile/longevc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology